Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.90
-0.0600-0.75%
Volume:14.12K
Turnover:111.25K
Market Cap:53.69M
PE:-0.69
High:8.07
Open:7.93
Low:7.81
Close:7.96
Loading ...
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 09, 2024

Major Issues Report

Form 8-K - Current report
Jan 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 03, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Dec 08, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Correspondence

Form CORRESP - Correspondence
Nov 01, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 01, 2023

Major Issues Report

Form 8-K - Current report